S Jayasinghe Selected Research

Vaccines

1/2019	Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy.
1/2018	Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Jayasinghe Research Topics

Disease

2	Pneumonia (Pneumonitis) 01/2021 - 01/2019
2	Pneumococcal Infections 01/2019 - 01/2018
2	Aspergillus meningitis 07/2007 - 12/2006
1	Type 2 Diabetes Mellitus (MODY) 09/2022
1	Insulin Resistance 09/2022
1	Infections 10/2013
1	Cicatrix (Scar) 10/2013
1	Fat Necrosis 10/2013
1	Inflammation (Inflammations) 10/2013
1	Hearing Loss (Hearing Impairment) 12/2006
1	Leukocytosis (Pleocytosis) 12/2006
1	Malaria 12/2006

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 01/2019 - 01/2018
1	HydrogenIBA 09/2022
1	Blood Glucose (Blood Sugar)IBA 09/2022
1	Hormones (Hormone)IBA 09/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2022
1	Insulin (Novolin)FDA Link 09/2022
1	FructosamineIBA 09/2022
1	AcidsIBA 01/2021
1	carbapenemaseIBA 01/2021
1	Meropenem (Merrem)FDA LinkGeneric 01/2021
1	Conjugate VaccinesIBA 01/2018
1	Detergents (Detergent)IBA 10/2013
1	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2006
1	Glucose (Dextrose)FDA LinkGeneric 12/2006
1	Voriconazole (Vfend)FDA LinkGeneric 12/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2006

Therapy/Procedure

2	Cesarean Section (Caesarean Section) 07/2007 - 12/2006
1	Meditation 09/2022
1	Mesotherapy 10/2013
1	Aftercare (After-Treatment) 12/2006